20829454|t|Tau reduction prevents Abeta-induced defects in axonal transport.
20829454|a|Amyloid-beta (Abeta) peptides, derived from the amyloid precursor protein, and the microtubule-associated protein tau are key pathogenic factors in Alzheimer's disease (AD). How exactly they impair cognitive functions is unknown. We assessed the effects of Abeta and tau on axonal transport of mitochondria and the neurotrophin receptor TrkA, cargoes that are critical for neuronal function and survival and whose distributions are altered in AD. Abeta oligomers rapidly inhibited axonal transport of these cargoes in wild-type neurons. Lowering tau levels prevented these defects without affecting baseline axonal transport. Thus, Abeta requires tau to impair axonal transport, and tau reduction protects against Abeta-induced axonal transport defects.
20829454	0	3	Tau	Gene	4137
20829454	23	28	Abeta	Gene	351
20829454	66	78	Amyloid-beta	Gene	351
20829454	80	85	Abeta	Gene	351
20829454	114	139	amyloid precursor protein	Gene	351
20829454	149	179	microtubule-associated protein	Gene	51115
20829454	180	183	tau	Gene	4137
20829454	214	233	Alzheimer's disease	Disease	MESH:D000544
20829454	235	237	AD	Disease	MESH:D000544
20829454	323	328	Abeta	Gene	351
20829454	333	336	tau	Gene	4137
20829454	403	407	TrkA	Gene	4914
20829454	509	511	AD	Disease	MESH:D000544
20829454	513	518	Abeta	Gene	351
20829454	612	615	tau	Gene	4137
20829454	698	703	Abeta	Gene	351
20829454	713	716	tau	Gene	4137
20829454	749	752	tau	Gene	4137
20829454	780	785	Abeta	Gene	351
20829454	Association	351	4137
20829454	Association	MESH:D000544	51115
20829454	Association	MESH:D000544	351
20829454	Association	MESH:D000544	4914
20829454	Association	MESH:D000544	4137

